Sarah Sheldrick is a seasoned professional in the field of psychological medicine and research, currently serving as Research Director and Project Manager at ConSynance Therapeutics, Inc. since June 2020. Prior experience includes roles as Biomarker Team Leader and Postdoctoral Researcher at the University of Oxford from November 2014 to October 2018, and as a Research Worker at the Institute of Psychiatry for a brief period in 2010. Sarah's academic accomplishments include a PhD in Psychological Medicine from King's College London, an MSc in Cognitive Brain Imaging, and a BSc in Psychology, all complemented by earlier positions in voluntary care and clinical psychology research at Aintree University Hospital NHS Foundation Trust and the University of Manchester.